Ranibizumab so với aflibercept trong điều trị tách rời biểu mô sắc tố với sự tưới máu do thoái hóa điểm vàng liên quan đến tuổi tác

Congdon N, O’Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P, Eye Diseases Prevalence Research Group (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477–485 Joachim N, Mitchell P, Burlutsky G, Kifley A, Wang JJ (2015) The incidence and progression of age-related macular degeneration over 15 years: the Blue Mountains Eye Study. Ophthalmology 122:2482–2489 Zając-Pytrus HM, Pilecka A, Turno-Kręcicka A, Adamiec-Mroczek J, Misiuk-Hojło M (2015) The dry form of age-related macular degeneration (AMD): the current concepts of pathogenesis and prospects for treatment. Adv Clin Exp Med 24:1099–1104 Mehta S (2015) Age-related macular degeneration. Prim Care 42:377–391 Holz FG, Pauleikhoff D, Klein R, Bird AC (2004) Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 137:504–510 Mrejen S, Sarraf D, Mukkamala SK, Freund KB (2013) Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina 33:1735–1762 Yannuzzi LA, Hope-Ross M, Slakter JS, Guyer DR, Sorenson JA, Ho AC, Sperber DE, Freund KB, Orlock DA (1994) Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 14:99–113 Pauleikhoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Bird AC (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–538 Doguizi S, Ozdek S (2014) Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina 34:1156–1162 Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431 Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65 Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS (2014) Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology 121:193–201 Inoue M, Arakawa A, Yamane S, Kadonosono K (2013) Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy. Retina 33:990–997 Wolf A, Rüping J, Neubauer AS, Mayer W, Ulbig M, Haritoglou C, Holz FG, Eter N, Kampik A (2013) Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab. Retina 33:1843–1849 Yüksel H, Türkcü FM, Sahin A, Sahin M, Cinar Y, Cingü AK, Ari S, Caça I (2013) One year results of anti-VEGF treatment in pigment epithelial detachment secondary to macular degeneration. Arq Bras Oftalmol 76:209–211 Chen E, Kaiser RS, Vander JF (2007) Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Retina 27:445–450 Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S (2010) Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Retina 30:1420–1425 Parodi MB, Iacono P, Papayannis A, Kontadakis SD, Cascavilla M, Pierro L, Gagliardi M, Bandello F (2013) Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series. Am J Ophthalmol 155:103–108 Broadhead GK, Hong T, Zhu M, Li H, Schlub TE, Wijeyakumar W, Chang AA (2015) Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina 35:975–981 Clemens CR, Wolf A, Alten F, Milojcic C, Heiduschka P, Eter N (2017) Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study. Acta Ophthalmol. https://doi.org/10.1111/aos.13359 Veritti D, Sarao V, Parravano M, Arias L, Varano M, Lanzetta P (2017) One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: a prospective study. Eur J Ophthalmol 27:74–79 Wasmuth S (2010) Pathogenetic concepts for pigment epithelial detachment in exudative AMD. Ophthalmologe 107:1109–1114 Ritter M, Bolz M, Sacu S, Deák GG, Kiss C, Pruente C, Schmidt-Erfurth UM (2010) Effect of intravitreal ranibizumab in avascular pigment epithelial detachment. Eye 24:962–968 Iordanous Y, Powell AM, Mao A, Hooper PL, Eng KT, Schwartz C, Kertes PJ, Sheidow TG (2014) Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration. Can J Ophthalmol 49:367–376 Stewart MW (2012) Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clin Ophthalmol 6:1175–1186 Chan CK, Abraham P, Meyer CH, Kokame GT, Kaiser PK, Rauser ME, Gross JG, Nuthi AS, Lin SG, Daher NS (2010) Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina 30:203–211 Chuang EL, Bird AC (1988) The pathogenesis of tears of the retinal pigment epithelium. Am J Ophthalmol 105:285–290